KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 141 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,196,060 | -26.4% | 3,131,388 | -1.7% | 0.00% | 0.0% |
| Q2 2023 | $5,699,507 | -59.9% | 3,184,082 | -12.8% | 0.00% | -66.7% |
| Q1 2023 | $14,207,681 | +10.3% | 3,652,360 | -6.0% | 0.00% | 0.0% |
| Q4 2022 | $12,882,647 | +18.2% | 3,885,353 | +94.6% | 0.00% | +50.0% |
| Q3 2022 | $10,901,000 | +300.6% | 1,996,546 | +231.0% | 0.00% | – |
| Q2 2022 | $2,721,000 | -66.2% | 603,249 | -44.7% | 0.00% | -100.0% |
| Q1 2022 | $8,047,000 | -15.4% | 1,091,817 | -26.2% | 0.00% | 0.0% |
| Q4 2021 | $9,511,000 | +20.5% | 1,478,983 | +9.1% | 0.00% | 0.0% |
| Q3 2021 | $7,893,000 | -38.0% | 1,355,977 | +9.8% | 0.00% | -50.0% |
| Q2 2021 | $12,738,000 | +24.2% | 1,234,394 | +26.6% | 0.00% | 0.0% |
| Q1 2021 | $10,256,000 | +56.6% | 975,016 | +130.5% | 0.00% | +100.0% |
| Q4 2020 | $6,549,000 | -62.4% | 423,075 | -64.5% | 0.00% | -80.0% |
| Q3 2020 | $17,407,000 | +198.2% | 1,192,238 | +286.8% | 0.01% | +150.0% |
| Q2 2020 | $5,837,000 | -82.1% | 308,232 | -81.9% | 0.00% | -86.7% |
| Q1 2020 | $32,661,000 | +7.8% | 1,700,203 | +7.6% | 0.02% | +15.4% |
| Q4 2019 | $30,302,000 | +92.0% | 1,580,694 | -3.7% | 0.01% | +85.7% |
| Q3 2019 | $15,784,000 | +185.1% | 1,640,789 | +77.5% | 0.01% | +250.0% |
| Q2 2019 | $5,537,000 | -49.5% | 924,333 | -50.8% | 0.00% | -60.0% |
| Q1 2019 | $10,972,000 | +265.4% | 1,878,704 | +486.2% | 0.01% | +400.0% |
| Q4 2018 | $3,003,000 | -38.6% | 320,470 | +11.5% | 0.00% | -50.0% |
| Q3 2018 | $4,894,000 | +51.7% | 287,317 | +51.2% | 0.00% | +100.0% |
| Q2 2018 | $3,227,000 | +92.0% | 189,962 | +51.7% | 0.00% | 0.0% |
| Q1 2018 | $1,681,000 | +222.6% | 125,240 | +130.6% | 0.00% | – |
| Q4 2017 | $521,000 | +31.9% | 54,308 | +51.1% | 0.00% | – |
| Q3 2017 | $395,000 | -28.6% | 35,930 | -41.2% | 0.00% | – |
| Q2 2017 | $553,000 | -56.4% | 61,137 | -38.1% | 0.00% | -100.0% |
| Q1 2017 | $1,269,000 | +193.8% | 98,829 | +114.9% | 0.00% | – |
| Q4 2016 | $432,000 | +51.0% | 45,984 | +56.7% | 0.00% | – |
| Q3 2016 | $286,000 | -5.6% | 29,353 | +28.4% | 0.00% | – |
| Q4 2015 | $303,000 | -95.0% | 22,859 | -96.0% | 0.00% | -100.0% |
| Q3 2015 | $6,091,000 | -50.6% | 578,452 | +27.6% | 0.01% | -45.5% |
| Q2 2015 | $12,333,000 | +1483.2% | 453,249 | +1680.0% | 0.01% | +1000.0% |
| Q1 2015 | $779,000 | +6981.8% | 25,463 | +8961.6% | 0.00% | – |
| Q4 2014 | $11,000 | -99.7% | 281 | -99.6% | 0.00% | -100.0% |
| Q2 2014 | $3,673,000 | – | 78,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $35,031,000 | 23.03% |
| Palo Alto Investors LP | 5,267,652 | $81,543,000 | 4.28% |
| Fairmount Funds Management LLC | 702,351 | $10,872,000 | 3.89% |
| Birchview Capital, LP | 188,000 | $2,910,000 | 1.68% |
| Mesirow Financial Investment Management, Inc. | 22,303 | $345,250,000 | 1.09% |
| EMERALD ADVISERS, LLC | 1,822,781 | $28,217,000 | 0.94% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,661,236 | $25,716,000 | 0.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,552,504 | $24,033,000 | 0.85% |
| Altium Capital Management LP | 133,951 | $2,074,000 | 0.77% |
| Hood River Capital Management LLC | 931,754 | $14,424,000 | 0.48% |